Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 13 | $2,296,479 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 06 Mar 2025 17:17 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 05 Mar 2025 | Sale | 5,569 | 25.1013 | 139,789 | D |
| 30 Jan 2025 12:20 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 29 Jan 2025 | Sale | 695 | 29.5236 | 20,519 | D |
| 23 Jan 2025 15:41 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 22 Jan 2025 | Sale | 3,323 | 30.4255 | 101,104 | D |
| 21 Jan 2025 16:14 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 17 Jan 2025 | Sale | 2,201 | 29.9582 | 65,938 | D |
| 14 Jan 2025 16:30 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 13 Jan 2025 | Sale | 4,965 | 28.7021 | 142,506 | D |
| 13 Dec 2024 16:15 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 11 Dec 2024 | Sale | 5,000 | 34.235 | 171,175 | D |
| 13 Feb 2024 17:06 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 12 Feb 2024 | Sale | 781 | 67.7669 | 52,926 | D |
| 31 Jan 2024 16:38 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 29 Jan 2024 | Sale | 906 | 64.1382 | 58,109 | D |
| 23 Jan 2024 18:17 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 22 Jan 2024 | Sale | 4,184 | 64.996 | 271,943 | D |
| 17 Jan 2024 16:38 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 16 Jan 2024 | Sale | 4,240 | 66.8086 | 283,268 | D |
| 20 Dec 2023 16:18 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 19 Dec 2023 | Sale | 2,300 | 57.3827 | 131,980 | D |
| 20 Dec 2023 16:18 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 19 Dec 2023 | Sale | 1,605 | 57.0041 | 91,492 | D |
| 06 Jul 2023 16:20 | APLS | Apellis Pharmaceuticals Inc | WATSON DAVID O. | General Counsel | 03 Jul 2023 | Sale | 8,510 | 89.98 | 765,730 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)